Single-agent adriamycin followed by combination hexamethylmelamine-cyclophosphamide for advanced ovarian carcinoma
- 1 October 1982
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 14 (2) , 262-270
- https://doi.org/10.1016/0090-8258(82)90098-1
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Surgery for common epithelial tumors of the ovaryCancer, 1981
- Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycinCancer, 1981
- COMBINATION CHEMOTHERAPY FOR ADVANCED OVARIAN-CANCER - A PROSPECTIVE RANDOMIZED TRIAL COMPARING HEXAMETHYLMELAMINE AND CYCLOPHOSPHAMIDE TO DOXORUBICIN AND CYCLOPHOSPHAMIDE1981
- Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinomaCancer, 1980
- Low-dose cyclophosphamide versus adriamycin plus cyclophosphamide in advanced ovarian cancerCancer Chemotherapy and Pharmacology, 1980
- Hexamethylmelamine: An evaluation of its role in the treatment of ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1979
- Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemiaBritish Journal of Cancer, 1975
- AdriamycinAnnals of Internal Medicine, 1974
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965
- Survival Curve for Cancer Patients Following TreatmentJournal of the American Statistical Association, 1952